4SC AG INH. O.N./ DE000A3E5C40 /
8/2/2024 9:21:42 PM | Chg. -0.070 | Volume | Bid9:21:42 PM | Ask9:21:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
4.440EUR | -1.55% | - Turnover: - |
4.440Bid Size: - | 4.850Ask Size: - | 46.02 mill.EUR | 0.00% | - |
GlobeNewswire
12/5/2023
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
4/1/2019
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
6/11/2018
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018